EG-626: not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000818:Animals; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors; D003094:Collagen / Q000037:antagonists & inhibitors; D004357:Drug Synergism; D011464:Epoprostenol / Q000378:metabolism*; D010793:Phthalazines / Q000008:administration & dosage / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000378:metabolism*; D011724:Pyridazines / Q000494:pharmacology*; D011817:Rabbits; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors*; D013931:Thromboxanes / Q000037:antagonists & inhibitors*
D001095:Arachidonic Acids; D010793:Phthalazines; D011453:Prostaglandins; D011724:Pyridazines; D013931:Thromboxanes; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D003094:Collagen; D011464:Epoprostenol